Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Vericiguat Drug Analysis Report 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Drug analysis: vericiguat" drug pipelines has been added to ResearchAndMarkets.com's offering.

Vericiguat is a first-in-class soluble guanylate cyclase (sGC) stimulator that acts to increase levels of cyclic guanosine monophosphate (cGMP) via the nitric oxide-sGC-cGMP pathway. In heart failure, there is reduced bioavailability of nitric oxide due to systemic inflammation and vascular dysfunction, resulting in a reduction in cGMP synthesis. Disruption in the nitric oxide-sGC-cGMP pathway results in issues in the regulation of myocardial and renal function, thus resulting in increased potential for myocardial damage.

Product Profiles

List of Figures

Figure 1: Vericiguat for chronic heart failure - SWOT analysis

Figure 2: Drug assessment summary of vericiguat for chronic heart failure

Figure 3: Drug assessment summary of vericiguat for chronic heart failure

Figure 4: Vericiguat sales for chronic heart failure across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables

Table 1: Vericiguat drug profile

Table 2: Vericiguat Phase III trials in chronic heart failure

Table 3: Vericiguat Phase II data in chronic heart failure

Table 4: Vericiguat sales for chronic heart failure across the US, Japan, and five major EU markets, by country ($m), 2017-26

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qqj67v/vericiguat_drug?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215006143/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.